Skip to main content

OPPENHEIMER ASSET MANAGEMENT INC.

Position in CRL — Charles River Laboratories International, Inc.

CIK 1269119 NEW YORK, NY

Position in CRL

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$4,997,316
+$1,561,117 QoQ
Shares Held
22,035
+10.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#134
of 569 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

OPPENHEIMER ASSET MANAGEMENT INC. holds $122,739,286 across 17 Diagnostics & Research names. CRL ranks #7 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 CRL
Charles River Laboratories International, Inc.
This page
22,035 $4,997,316

All Filings in CRL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,997,316 22,035
2026-03-31 $3,436,199 19,920
2025-12-31 $4,134,420 20,726
2025-09-30 $3,552,422 22,705
2025-06-30 $3,542,439 23,347
2025-03-31 $5,655,937 37,576
2024-12-31 $6,074,261 32,905
2024-09-30 $9,170,134 46,556
2024-06-30 $9,821,843 47,545
2024-03-31 $11,735,926 43,314
2023-12-31 $10,483,864 44,348
2023-09-30 $9,414,484 48,038
2023-06-30 $10,258,095 48,790
2023-03-31 $9,464,144 46,894
2022-12-31 $9,119,766 41,853
2022-09-30 $8,281,737 42,082
2022-06-30 $7,624,818 35,635
2022-03-31 $10,228,028 36,018
2021-12-31 $10,418,340 27,651
2021-09-30 $10,838,775 26,265
2021-06-30 $10,492,039 28,363
2021-03-31 $8,056,691 27,798
2020-12-31 $4,149,674 16,608
2020-09-30 $3,868,444 17,083
2020-06-30 $3,624,212 20,787
2020-03-31 $2,365,175 18,740